Drug Side Effects
Search
HAEMORRHAGIC TUMOUR NECROSIS
HAEMORRHAGIC TUMOUR NECROSIS
was reported 47 times
HAEMORRHAGIC TUMOUR NECROSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Ergot Derivative [EPC]
1
0.0002
1
Progesterone [EPC]
2
0.0001
2
Androgen [EPC]
2
0.0001
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
6
0.0001
4
Vascular Endothelial Growth Factor Inhibitor [EPC]
8
0.0000
5
Platinum-based Drug [EPC]
11
0.0000
6
Microtubule Inhibitor [EPC]
5
0.0000
7
Topoisomerase Inhibitor [EPC]
2
0.0000
8
Nucleoside Metabolic Inhibitor [EPC]
7
0.0000
9
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
10
Progestin [EPC]
5
0.0000
11
Nitrate Vasodilator [EPC]
1
0.0000
12
Kinase Inhibitor [EPC]
6
0.0000
13
Angiotensin 2 Receptor Blocker [EPC]
3
0.0000
14
Insulin Analog [EPC]
4
0.0000
15
Parathyroid Hormone Analog [EPC]
1
0.0000
16
Alkylating Drug [EPC]
2
0.0000
17
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
18
Aldosterone Antagonist [EPC]
1
0.0000
19
beta-Adrenergic Blocker [EPC]
1
0.0000
20
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
21
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
22
Corticosteroid [EPC]
3
0.0000
23
Loop Diuretic [EPC]
1
0.0000
24
Platelet Aggregation Inhibitor [EPC]
1
0.0000
25
Proton Pump Inhibitor [EPC]
1
0.0000
26
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000